Baclofen for the treatment of alcohol dependence and possible role of comorbid anxiety

Alcohol and Alcoholism

Volumn 49, Issue 6, 2014, Pages 654-660

  Morley, K C ^a   Baillie, A ^b   Leung, S ^a   Addolorato, G ^c   Leggio, L ^d,e,f   Haber, P S ^a,g  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c CATHOLIC UNIVERSITY   (Italy)

^d NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

^f BROWN UNIVERSITY   (United States)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACLOFEN; PLACEBO; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT;

ADULT; ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DROWSINESS; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; INSOMNIA; INTENTION TO TREAT ANALYSIS; MALE; MEDICATION COMPLIANCE; MOTIVATION; MYALGIA; NAUSEA; PARESTHESIA; PATIENT COMPLIANCE; POST HOC ANALYSIS; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; RASH; RELAPSE; SIDE EFFECT; SOMNOLENCE; TREATMENT OUTCOME; XEROSTOMIA; ANXIETY; COMPLICATION; MIDDLE AGED; PSYCHOLOGY; RECURRENT DISEASE; STATISTICS AND NUMERICAL DATA;

ADULT; ALCOHOL ABSTINENCE; ALCOHOLISM; ANXIETY; BACLOFEN; DOUBLE-BLIND METHOD; FEMALE; GABA-B RECEPTOR AGONISTS; HUMANS; MALE; MIDDLE AGED; RECURRENCE; TREATMENT OUTCOME;

EID: 84937410245     PISSN: 07350414     EISSN: 14643502     Source Type: Journal    
DOI: 10.1093/alcalc/agu062     Document Type: Article

References (41)

1. Addolorato G, Leggio L. (2010) Safety and efficacy of baclofen in the treatment of alcohol-dependent patients. Curr Pharm Des 16:2113-7.
2. Addolorato G, Caputo F, Capristo E et al. (2002) Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomised controlled study. Alcohol Alcohol 37:504-08.
3. Addolorato G, Leggio L, Abenavoli L et al. (2006) Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam. Am J Med 119:276.e13-8.
4. Addolorato G, Leggio L, Ferrulli A et al. (2007) Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study. Lancet 370:1915-22.
5. Addolorato G, Leggio L, Ferrulli A et al. (2011) Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial. Alcohol Alcohol 46:312-7.
6. Agabio R, Colombo G. (2014) GABAB receptor ligands for the treatment of alcohol use disorder: preclinical and clinical evidence. Front Neuro Sci 8:140.
7. Allan C, Smith I, Mellin M. (2002) Changes in psychological symptoms during ambulant detoxification. Alcohol Alcohol 37:241-44.
8. Anton RF. (2000) Obsessive-compulsive aspects of craving: development of the Obsessive Compulsive Drinking Scale. Addiction 95:211-7.
9. Breslow MF, Fankhauser MP, Potter RL et al. (1989) Role of gammaaminobutyric acid in antipanic drug efficacy. Am J Psychiatry 146:353-6.
10. Cannistraro PA, Rauch SL. (2003) Neural circuitry of anxiety: evidence from structural and functional neuroimaging studies. Psychopharmacol Bull 37:8-25.
11. Colombo G, Addolorato G, Agabio R et al. (2004) Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics. Neurotox Res 6:403-14.
12. Cornelius JR, Salloum IM, Ehler JG et al. (1997) Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial (see comments). Arch Gen Psychiatry 54:700-5.
13. Drake RG, Davis LL, Cates ME et al. (2003) Baclofen treatment for chronic posttraumatic stress disorder. Ann Pharmacother 37:1177-81.
14. Driessen M, Meier S, Hill A et al. (2001) The course of anxiety, depression and drinking behaviours after completed detoxification in alcoholics with and without comorbid anxiety and depressive disorders. Alcohol Alcohol 36:249-55.
15. Evans SM, Bisaga A. (2009) Acute interaction of baclofen in combination with alcohol in heavy social drinkers. Alcohol Clin Exp Res 33:19-30.
16. Falco AM, McDonald CG, Smith RF. (2014) Anxiety status affects nicotine- and baclofen-induced locomotor activity, anxiety, and single-trial conditioned place preference in male adolescent rats. Dev Psychobiol 56:1352-64.
17. Flannery BA, Volpicelli JR, Pettinati H. (1999) Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 28:1289-95.
18. Flannery BA, Garbutt JC, Cody MW et al. (2004) Baclofen for alcohol dependence: a preliminary open-label study. Alcohol Clin Exp Res 28:1517-23.
19. Franklin TR, Shin J, Jagannathan K et al. (2012) Acute baclofen diminishes resting baseline blood flow to limbic structures: a perfusion fMRI study. Drug Alcohol Depend 125:60-6.
20. Garbutt JC, Kampov-Polevoy AB, Gallop R et al. (2012) Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial. Alcohol Clin Exp Res 34:1849-57.
21. Greenfield SF, Weiss RD, Muenz LR et al. (1998) The effect of depression on return to drinking. Arch Gen Psychiatry 55:259-65.
22. Haver B. (2003) Comorbid psychiatric disorders predict and influence treatment outcome in female alcoholics. Eur Addict Res 9:39-44. Krupitsky EM, Burakov AM, Ivanov VB et al. (1993) Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug Alcohol Depend 33:157-63.
23. Krupitsky EM, Burakov AM, Ivanov VB et al. (1993) Baclofen administration for the treatment of affective disorders in alcoholic patients. Drug Alcohol Depend 33:157-63.
24. Leggio L, Garbutt JC, Addolorato G. (2010) Effectiveness and safety of baclofen in the treatment of alcohol dependent patients. CNS Neurol Disord Drug Targets 9:33-44.
25. Leggio L, Ferrulli A, Zambon A et al. (2012) Baclofen promotes alcohol abstinence in alcohol dependent cirrhotic patients with hepatitis C virus (HCV) infection. Addict Behav 37:561-4.
26. Leggio L, Zywiak WH, McGeary JE et al. (2013) A human laboratory pilot study with baclofen in alcoholic individuals. Pharmacol Biochem Behav 103:784-91.
27. Lyon JE, Khan RA, Gessert CE et al. (2011) Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebocontrolled trial. J Hosp Med 6:469-74.
28. Maccioni P, Colombo G. (2009) Role of the GABA(B) receptor in alcohol-seeking and drinking behavior. Alcohol 43:555-8.
29. Manteghi AA, Hebrani P, Mortezania M et al. (2014) Baclofen add-on to citalopram in treatment of posttraumatic stress disorder. J Clin Psychopharmacol 34:240-3.
30. Milad MR, Rauch SL. (2007) The role of the orbitofrontal cortex in anxiety disorders. Ann N Y Acad Sci 1121:546-61.
31. Nutt DJ, King LA, Phillips LD. (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376:1558-65.
32. Schulz KF, Altman DG, Moher D. (2010) CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Br Med J 340:c332.
33. Sheehan DV, Lecrubier Y, Sheehan KH et al. (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22-33.
34. Skinner HA, Allen BA. (1982) Alcohol dependence syndrome: measurement and validation. J Abnorm Psychol 91:199-209.
35. Sobell LC, Sobell MB, Leo GL et al. (1988) Reliability of a timeline followback method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 83:393-402.
36. Spielberger CD. (1983) Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press, Inc.
37. Sullivan JT, Sykora K, Schneiderman J et al. (1989) Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict 84:1353-57.
38. Ten Have TR, Kunselman AR, Pulkstenis EP et al. (1998) Mixed effects logistic regression models for longitudinal binary response data with informative drop-out. Biometrics 54:367-83.
39. Volpicelli JR, Pettinati HM, McLellan AT et al. (2001) Combining Medication and Psychosocial Treatments for Addictions: the BRENDA Approach. New York: Guilford.
40. Willinger U, Lenzinger E, Hornik K et al. (2002) Anxiety as a predictor of relapse in detoxifed alcohol-dependent patients. Alcohol Alcohol 37:609-12.
41. Young KA, Franklin TR, Roberts DC et al. (2014) Nipping cue reactivity in the bud: baclofen prevents limbic activation elicited by subliminal drug cues. J Neurosci 34:5038-43.